Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|August 19, 2015
DPP4 in DiabetesDiana Röhrborn, Nina Wronkowitz, Juergen EckelFrontiers of Hormone Research|June 20, 2014
Adipose tissue dysfunction and inflammation in cardiovascular diseaseNina Wronkowitz, Tania Romacho, Henrike Sell, et al.Cardiovascular Diabetology|July 17, 2016
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and functionThorsten Hartmann, Sabrina Overhagen, D Margriet Ouwens, et al.Biochimica Et Biophysica Acta|June 15, 2014
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2Nina Wronkowitz, Sven W Görgens, Tania Romacho, et al.Journal of Hypertension|February 20, 2016
Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 releaseTania Romacho, Susana Vallejo, Laura A Villalobos, et al.Biochimica Et Biophysica Acta|December 17, 2013
Adipocyte-derived factors impair insulin signaling in differentiated human vascular smooth muscle cells via the upregulation of miR-143Marcel Blumensatt, Nina Wronkowitz, Claudia Wiza, et al.Diabetes, Obesity & Metabolism|May 13, 2017
LAPS Insulin115: A novel ultra-long-acting basal insulin with a unique action profileNina Wronkowitz, Thorsten Hartmann, Sven Wolfgang Görgens, et al.Diabetes|May 20, 2011
Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndromeDaniela Lamers, Susanne Famulla, Nina Wronkowitz, et al.Pageof 1